The EMPOWER CAD trial will evaluate Shockwave’s intravascular lithotripsy system in female patients undergoing a percutaneous coronary intervention for coronary artery disease. Principal investigator Alexandra Lansky spoke to Medtech Insight about the first-of-its kind study in this understudied population.
A new study sponsored from Shockwave Medical, which specializes in coronary intravascular lithotripsy (IVL), is designed to close the deadly gender gap in coronary artery disease (CAD).
Heart disease kills more women in the US than any other disease — a fact not even many women are...